Extra information for the Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) Integrated Scientific Advice (ISA) service.
Similar Posts
Research: Improving information supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs
Public Assessment Report on improving information regarding addiction, dependence, withdrawal, and tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs.
Field safety notices: guidance for manufacturers
How to write clear and effective field safety notices (FSNs) for medical devices.
MHRA Safety Roundup: October 2025
Summary of the latest safety advice for medicines and medical device users
Guidance: AI Airlock Phase 2 application
The call for application for phase 2 of the AI Airlock is now open. This page contains information on eligibility and how to apply
Isotretinoin: an expert review of suspected psychiatric and sexual side effects
The review of the safety of isotretinoin has concluded.
Field Safety Notices: 29 September to 3 October 2025
List of Field Safety Notices from 29 September to 3 October 2025.